A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population.

BMJ Open
Mattias NeytStefaan Van De Sande

Abstract

Patients with severe aortic stenosis and coexisting non-cardiac conditions may be at high risk for surgical replacement of the aortic valve or even be no candidates for surgery. In these patients, transcatheter aortic valve implantation (TAVI) is suggested as an alternative. Results of the PARTNER (Placement of AoRTic TraNscathetER Valve) trial comparing the clinical effectiveness of TAVI with surgical valve replacement and standard therapy were published. The authors assessed the cost-effectiveness of TAVI in Belgium. A Markov model of incremental costs, effects (survival and quality of life) and incremental cost-effectiveness of TAVI was developed. The impact on survival, number of events and quality of life was based on the PARTNER trial. Costs per event were context specific. In high-risk operable patients, even if the minor differences in 30-day and 1-year mortality are taken into account, the incremental cost-effectiveness ratio (ICER) remains on average above €750 000 per quality-adjusted life-year (QALY) gained (incremental cost: €20 400; incremental effect: 0.03 QALYs). In inoperable patients, an ICER of €44 900 per QALY (incremental cost: €33 200; incremental effect: 0.74 QALYs) is calculated, including a life-long ex...Continue Reading

Citations

Sep 18, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Ruben L J OsnabruggeDavid J Cohen
Feb 25, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·W Ken Redekop
May 20, 2014·Progress in Cardiovascular Diseases·Peter M PollakDavid R Holmes
Sep 17, 2013·The Journal of Thoracic and Cardiovascular Surgery·Antonio MiceliMattia Glauber
Nov 28, 2013·The Journal of Thoracic and Cardiovascular Surgery·Praveen IndraratnaChristopher Cao
Aug 23, 2012·Age and Ageing·Panagiota GeorgiadouVassilis Voudris
Feb 2, 2013·Journal of Medical Economics·Michael J Reardon, Matthew R Reynolds
Jul 9, 2013·Revista española de anestesiología y reanimación·F E Fernández SuárezL Argüelles Tamargo
Jan 15, 2016·Journal of the American College of Cardiology·Matthew R ReynoldsUNKNOWN CoreValve US High Risk Pivotal Trial Investigators
Sep 28, 2015·The Annals of Thoracic Surgery·Gorav AilawadiJeffrey B Rich
Dec 8, 2015·International Journal of Cardiology·A van GiessenH Koffijberg
Jul 2, 2014·Journal of Cardiac Surgery·Laurens W WollersheimBas A de Mol
Jul 8, 2014·The Canadian Journal of Cardiology·Gautam Gadey, Matthew R Reynolds
May 21, 2013·Journal of the American College of Cardiology·John G Webb, Marco Barbanti
Mar 19, 2013·Journal of the American College of Cardiology·Matthew R Reynolds, David J Cohen
Mar 19, 2013·Journal of the American College of Cardiology·Christopher CaoTristan D Yan
Dec 29, 2013·The Heart Surgery Forum·Siyamek Neragi-Miandoab
Jul 11, 2014·Journal of Cardiovascular Medicine·Giuseppe RescignoLucia Torracca
Dec 10, 2014·Applied Health Economics and Health Policy·Andrea Iannaccone, Thomas H Marwick
Oct 27, 2015·BMC Cardiovascular Disorders·Jochen ReinöhlManfred Zehender
Feb 1, 2017·Health Economics·Rosanna TarriconeValentina Prevolnik Rupel
Jul 25, 2017·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Pedro A VillablancaHarish Ramakrishna
Jan 13, 2018·European Heart Journal. Quality of Care & Clinical Outcomes·Fotini GialamaNikolaos Maniadakis
Dec 3, 2014·Clinical Medicine Insights. Cardiology·Ioannis M Panayiotides, Evagoras Nikolaides
Jul 11, 2013·Circulation. Cardiovascular Quality and Outcomes·Matthew R Reynolds, David J Cohen
Dec 18, 2014·Circulation. Cardiovascular Interventions·Christopher CaoTristan D Yan
Nov 2, 2019·Innovations : Technology and Techniques in Cardiothoracic and Vascular Surgery·Olga N KislitsinaS Chris Malaisrie
Feb 2, 2013·Journal of Medical Economics·Mattias Neyt, Hans Van Brabandt
Feb 24, 2017·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Klaus KaierJochen Reinöhl
Aug 7, 2012·The Medical Journal of Australia·David W M Muller
Mar 8, 2017·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Simone A HuygensMaureen P M H Rutten-van Mölken
Jan 19, 2021·Asian Cardiovascular & Thoracic Annals·Fatima OsmanMohamad Bashir
Oct 30, 2020·Journal of Clinical Medicine·Antonio PiperataTomaso Bottio
Sep 5, 2018·The Annals of Thoracic Surgery·Alexander A BresciaDonald S Likosky
Apr 13, 2021·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Ting-An TaiAndreas Nikolaou

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00530894

Software Mentioned

@ Risk
TAVI
Excel
STACCATO

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.